Previous Section
Clinical Trials
10. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
- Author
- Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS;
- Institution
- Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
- Journal
- J Urol. 2007 Jan;177(1):84-9; discussion 89.
- Abstract URL
- Click here to view abstract
11. Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study.
- Author
- Dumez H; Martens M; Selleslach J; Guetens G; De Boeck G; Aerts R; De Bruijn EA; Maes RA; van Oosterom AT;
- Institution
- Department of General Medical Oncology, UZ Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. herlinde.dumez@uz.kuleuven.be
- Journal
- Anticancer Drugs. 2007 Feb;18(2):211-8.
- Abstract URL
- Click here to view abstract
12. Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.
- Author
- Galsky MD; Iasonos A; Mironov S; Scattergood J; Boyle MG; Bajorin DF;
- Institution
- Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. matthew.galsky@usoncology.com
- Journal
- Cancer. 2007 Feb 1;109(3):549-55.
- Abstract URL
- Click here to view abstract
13. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
- Author
- Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI;
- Institution
- The Prostate Centre at Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
- Journal
- Clin Cancer Res. 2008 Mar 1;14(5):1510-8.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
